Clinical Trial Update: Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating front-line nivolumab therapy with salvage nivolumab plus ipilimumab in patients with advanced renal cell carcinoma has completed and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Michael B. Atkins, MD | Conditions: Advanced Renal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2025-07-10